Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Toll-Like Receptor 3 Ligand Enhances Protective Effects of Vaccination Against Marek's Disease Virus and Hinders Tumor Development in Chickens

2 Aug 2012

Abstract excerpt

Marek's disease (MD) is caused by Marek's disease virus (MDV). Various vaccines including herpesvirus of turkeys (HVT) have been used to control this disease. However, HVT is not able to completely protect against very virulent strains of MDV. The objective of this study was to determine whether a vaccination protocol consisting of HVT and a Toll-like receptor (TLR) ligand could enhance protective efficacy of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesvirus Infections and Treatments
Share to Immune Response and Inflammation
Share to Immunotherapy and Immune Responses

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22857262
DOI: 10.1089/vim.2012.0033

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Toll-Like Receptor 3 Ligand Enhances Protective Effects of Vaccination Against Marek's Disease Virus and Hinders Tumor Development in ChickensPMID 22857262Read ↗

Marek’s disease in chickens: a review with focus on immunologySemantic proximity Read ↗

Immune escape of avian oncogenic Marek’s disease herpesvirus and antagonistic host immune responsesSemantic proximity Read ↗

Use of Marek’s disease vaccines: could they be driving the virus to increasing virulence?Semantic proximity Read ↗

Immunity to Marek's disease: where are we now?Semantic proximity Read ↗

Load of Challenge Marek's Disease Virus DNA in Blood as a Criterion for Early Diagnosis of Marek's Disease TumorsSemantic proximity Read ↗

Latest Insights into Marek’s Disease Virus Pathogenesis and TumorigenesisSemantic proximity Read ↗

The long view: 40 years of Marek's disease research and<i>Avian Pathology</i>Semantic proximity Read ↗

Marek’s disease virus: lytic replication, oncogenesis and controlSemantic proximity Read ↗

Reduction of Marek's Disease Virus Infection by Toll-Like Receptor Ligands in Chicken Embryo Fibroblast CellsSemantic proximity Read ↗

Differential expression of Toll-like receptor genes in lymphoid tissues between Marek's disease virus-infected and noninfected chickensSemantic proximity Read ↗

Spotlight on avian pathology: Marek’s diseaseSemantic proximity Read ↗

Marek's disease: an update on oncogenic mechanisms and control.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.